Cryptococcal Meningitis in a Fingolimod-Treated Patient: Positive Antigen Test a Year Before Onset.
作者信息
Aoki Reiji, Mori Masahiro, Suzuki Yo-Ichi, Uzawa Akiyuki, Masuda Hiroki, Uchida Tomohiko, Ohtani Ryohei, Kuwabara Satoshi
机构信息
Department of Neurology, Graduate School of Medicine, Chiba University, Japan.
出版信息
Neurol Clin Pract. 2021 Aug;11(4):e549-e550. doi: 10.1212/CPJ.0000000000001051.
Abstract
摘要
相似文献
1
Cryptococcal Meningitis in a Fingolimod-Treated Patient: Positive Antigen Test a Year Before Onset.一名接受芬戈莫德治疗的患者发生隐球菌性脑膜炎：发病前一年抗原检测呈阳性。
Neurol Clin Pract. 2021 Aug;11(4):e549-e550. doi: 10.1212/CPJ.0000000000001051.
2
Cryptococcal meningitis in a multiple sclerosis patient treated with Fingolimod: a case report and review of imaging findings.一名接受芬戈莫德治疗的多发性硬化症患者发生新型隐球菌性脑膜炎：病例报告及影像学表现综述
Clin Imaging. 2019 Mar-Apr;54:53-56. doi: 10.1016/j.clinimag.2018.11.005. Epub 2018 Nov 14.
3
Cryptococcal meningitis after fingolimod discontinuation in a patient with multiple sclerosis.停用地芬戈莫德后发生的隐球菌性脑膜炎：多发性硬化症病例报告
Mult Scler Relat Disord. 2016 Sep;9:47-9. doi: 10.1016/j.msard.2016.06.007. Epub 2016 Jun 23.
4
Serum cyrptococcal antigen: diagnostic value in the diagnosis of AIDS-related cryptococcal meningitis.血清隐球菌抗原：在艾滋病相关隐球菌性脑膜炎诊断中的诊断价值。
J Med Assoc Thai. 1999 Jan;82(1):65-71.
5
Symptomatic Cryptococcal Meningitis with Negative Serum and Cerebrospinal Fluid Cryptococcal Antigen Tests.血清和脑脊液隐球菌抗原检测均为阴性的症状性隐球菌脑膜炎
HIV AIDS (Auckl). 2021 Sep 1;13:861-865. doi: 10.2147/HIV.S328084. eCollection 2021.
6
Immunologic mechanisms of fingolimod and the role of immunosenescence in the risk of cryptococcal infection: A case report and review of literature.芬戈莫德的免疫机制及免疫衰老在隐球菌感染风险中的作用：病例报告及文献复习。
Mult Scler Relat Disord. 2016 Sep;9:158-62. doi: 10.1016/j.msard.2016.07.015. Epub 2016 Aug 4.
7
Cryptococcal meningitis causing obstructive hydrocephalus in a patient on fingolimod.在一名服用芬戈莫德的患者中，隐球菌性脑膜炎导致梗阻性脑积水。
BMJ Case Rep. 2017 Jul 6;2017:bcr-2017-220026. doi: 10.1136/bcr-2017-220026.
8
Case report: chronic relapsing cryptococcal meningitis in a patient with low mannose-binding lectin and a low naïve CD4 cell count.病例报告：低甘露糖结合凝集素和初始 CD4 细胞计数低的患者中慢性复发性隐球菌性脑膜炎。
BMC Infect Dis. 2019 Oct 15;19(1):846. doi: 10.1186/s12879-019-4515-0.
9
Correlation between serum cryptococcal antigen titre and meningitis in immunocompetent patients.血清隐球菌抗原滴度与免疫功能正常患者脑膜炎的相关性。
J Med Microbiol. 2018 Oct;67(10):1515-1518. doi: 10.1099/jmm.0.000830. Epub 2018 Aug 23.
10
Cryptococcal antigenemia is associated with meningitis or death in HIV-infected adults with CD4 100-200 cells/mm.隐球菌抗原血症与 CD4 细胞计数为 100-200 个/立方毫米的 HIV 感染成人的脑膜炎或死亡相关。
BMC Infect Dis. 2020 Jan 20;20(1):61. doi: 10.1186/s12879-020-4798-1.
引用本文的文献
1
An atypical presentation of immune reconstitution inflammatory syndrome (IRIS) in a patient with cryptococcal meningitis in the setting of fingolimod therapy for multiple sclerosis.在一名患有隐球菌性脑膜炎的患者中，免疫重建炎症综合征（IRIS）的非典型表现，该患者正接受用于治疗多发性硬化症的芬戈莫德治疗。
IDCases. 2025 Jun 6;41:e02280. doi: 10.1016/j.idcr.2025.e02280. eCollection 2025.
2
Fingolimod-associated cryptococcal meningitis in a patient with Multiple Sclerosis: A case report and literature review.一名多发性硬化症患者中与芬戈莫德相关的隐球菌性脑膜炎：病例报告及文献综述
IDCases. 2025 Jan 10;39:e02150. doi: 10.1016/j.idcr.2025.e02150. eCollection 2025.
3
Cryptococcosis Associated With Biologic Therapy: A Narrative Review.生物治疗相关的隐球菌病：一篇叙述性综述。
Open Forum Infect Dis. 2024 Jun 26;11(7):ofae316. doi: 10.1093/ofid/ofae316. eCollection 2024 Jul.
本文引用的文献
1
Cryptococcal meningitis in a multiple sclerosis patient treated with Fingolimod: a case report and review of imaging findings.一名接受芬戈莫德治疗的多发性硬化症患者发生新型隐球菌性脑膜炎：病例报告及影像学表现综述
Clin Imaging. 2019 Mar-Apr;54:53-56. doi: 10.1016/j.clinimag.2018.11.005. Epub 2018 Nov 14.
2
Cryptococcal meningitis: epidemiology, immunology, diagnosis and therapy.隐球菌性脑膜炎：流行病学、免疫学、诊断与治疗。
Nat Rev Neurol. 2017 Jan;13(1):13-24. doi: 10.1038/nrneurol.2016.167. Epub 2016 Nov 25.
3
Immunologic mechanisms of fingolimod and the role of immunosenescence in the risk of cryptococcal infection: A case report and review of literature.芬戈莫德的免疫机制及免疫衰老在隐球菌感染风险中的作用：病例报告及文献复习。
Mult Scler Relat Disord. 2016 Sep;9:158-62. doi: 10.1016/j.msard.2016.07.015. Epub 2016 Aug 4.
4
Fingolimod for relapsing-remitting multiple sclerosis.芬戈莫德用于复发缓解型多发性硬化症。
Cochrane Database Syst Rev. 2016 Apr 19;4(4):CD009371. doi: 10.1002/14651858.CD009371.pub2.
5
Disease-modifying treatments for multiple sclerosis - a review of approved medications.用于治疗多发性硬化症的疾病修正疗法——已获批药物综述
Eur J Neurol. 2016 Jan;23 Suppl 1(Suppl 1):18-27. doi: 10.1111/ene.12883.
6
Cryptococcal Meningoencephalitis in a Patient With Multiple Sclerosis Treated With Fingolimod.用芬戈莫德治疗的多发性硬化症患者发生的隐球菌性脑膜脑炎
JAMA Neurol. 2015 Oct;72(10):1203-5. doi: 10.1001/jamaneurol.2015.1746.
7
Disseminated cryptococcosis in a patient with multiple sclerosis treated with fingolimod.用芬戈莫德治疗的多发性硬化症患者发生播散性隐球菌病。
Neurology. 2015 Sep 15;85(11):1001-3. doi: 10.1212/WNL.0000000000001929. Epub 2015 Aug 19.
Zotero 插件